brain cancer

Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells. Anne Trafton | MIT News Publication Date: December 3, 2025 Caption: In tests in human cancer cells, a derivative of verticillin A showed particular promise against a type of pediatric brain cancer called diffuse midline glioma. Credits: Credit: MIT […]

by University of Maryland School of Medicine edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: University of Maryland School of Medicine Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients led by

by Ananya Sen, University of Michigan Medical School edited by Lisa Lock, reviewed by Robert Egan   Brain cells use sugar (white) to make chemicals (green) that allow the brain to function properly. Glioblastomas, on the other hand, converted sugar into molecules (red) that help them invade the surrounding tissues. Credit: Justine Ross, Michigan Medicine Glioblastomas are the

by Peter MacCallum Cancer Centre edited by Lisa Lock, reviewed by Robert Egan Victorian brain cancer researchers have used an innovative process to learn how a new drug suppresses tumour activity and provides hope to patients with low-grade gliomas (LGG). It’s the first clinical trial to be conducted through the pioneering Brain Perioperative platform, or “BrainPOP.” Credit: Peter

by University of Rochester Medical Center edited by Lisa Lock, reviewed by Robert Egan   Credit: Pixabay/CC0 Public Domain Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by an unlikely foe: a type of brain tumor called an astrocytoma that tends to afflict younger adults. They are

by University of Florida edited by Gaby Clark, reviewed by Robert Egan Mice engineered to develop brain tumors were treated with MT-125 alone and MT-125 plus a chemotherapy drug called suntinib. After four weeks, the mice treated with the drug combo showed a dramatic reduction in the tumors. Credit: Steven Rosenfeld, M.D., Ph.D., and Courtney Miller, Ph.D. A

by Virginia Tech edited by Sadie Harley, reviewed by Robert Egan   Using super-resolution microscopy, Assistant Professor Samy Lamouille discovered an association in the brain cancer glioblastoma between the protein connexin 43, shown in green, and parts of cells called microtubules, in magenta, that helps glioblastoma stem cells survive treatments and spread. Credit: Samy Lamouille/Virginia Tech A lab-designed